Institutional agreements

Created at the initiative of the Spanish Society of Medical Oncology (SEOM), ASEICA was launched to promote research and innovation as the main tool to improve survival and quality of life for all cancer sufferers.

AseBio has signed this association’s manifesto, which seeks a commitment from the government to invest in science and technology, among other issues.
 

We have established a collaboration agreement between AEAC and AseBio to raise awareness of and support the association’s action strategy, which focuses on working on the relationship between science and society, facilitating a two-way immersion process.

The Spanish Bioindustry Association (AseBio) works with the Digital Health Association (ASD) to explore the intersection between new digital technologies and biotechnology, as well as fostering dissemination and training activities on the potential new digital technologies offer for advances in biotechnology and to tackle the main challenges on the public agenda.

We have a collaboration agreement to carry out activities of interest to the biotechnology sector and to raise awareness of the activities of each party. The agreement gives Bioval members preferential terms for joining AseBio.

We have a collaboration agreement with CEPREDE to use data from the INE survey on the use of biotechnology to compile the main economic indicators for the biotechnology sector in Spain each year.

Nearly 200 organisations are part of this independent citizen initiative that aims to make science and scientific knowledge a source of information for political proposals.

#CienciaenelParlamento (Science in Parliament) aims to promote policies around science and boost scientific activity focused on society’s needs, and therefore works to import to Spain independent scientific advisory models similar to the parliamentary offices that exist in neighbouring countries.
 

We’ve established an agreement with specialised consultancy firm Clarke, Modet & Cº to get data on biotechnology patent applications and patents granted, for the yearly AseBio Report.

We have been part of CEOE since 2002, which gives us a seat on the Board of Directors of this organisation and allows us to take part in the sectorial work committees organised to debate topics of interest to the whole business sector.

AseBio, represented by its CEO, is a member of the VHIR Business Council, which advises the management and trustees of this research body, one of the most renowned in Spain.

This council, presided by businessman Lluís Bassat, also includes representatives of Fenin, CataloniaBIO & HealthTech, Specipig, Ferrer Group, la Caixa Banking Foundation, Ametic, Mondragon Health, Roche Diagnostics, Banco Sabadell, Laboratorios Esteve and Biocat, and its mission is to collaborate on detecting the sector’s needs, take part in joint projects and facilitate the VHIR’s access to public and private resources.
 

EBD Group and AseBio have reached a global collaboration agreement that allows us to negotiate advantageous conditions each year for our members who want to take part in the main international partnering events this company organises, which are among the most important in the world.

AseBio is a member of the Friends of the EOI programme. This programme allows AseBio members access to training, as friends of the EOI get 30% off training programmes, which is a great advantage and helps them grow and improve.

AseBio is a member of the European Bioindustry Association (EuropaBio), the body that defends the sector’s interests from its offices in Brussels. Belonging to this institution allows AseBio to take part in quarterly meetings of all member associations in Europe.

These meetings of the National Associations Council (NAC) complement our participation in various sector committees that discuss strategy on topics of interest to the sector continent-wide.
 

Collaboration agreement with Euro-Funding, a company that specialises in professional consulting services for European funding, giving AseBio and its members access to a service providing information and alerts on public funding for R&D in the EU.

The Spanish Bioindustry Association (AseBio) and the journal Farmabiotec have signed a collaboration agreement to make this magazine, which specialises in biotechnology applied to health, a new channel for dissemination of the association’s work.

The collaboration agreement with FECYT facilitates the exchange and dissemination of bibliometric data on scientific publications related to biotechnology.

The Spanish Federation of Biotechnologists (FEBiotec) and AseBio work in collaboration to promote and raise awareness of biotechnology. Both parties believe it is advisable to carry out activities in their common interest.

The Spanish Generic Medicines Association (AESEG), Association for Self-Care Health (ANEFP), Spanish Biosimilar Medicines Association (BIOSIM), Farmaindustria, Fenin and AseBio set up this forum in 2017 to reinforce collaboration with the administration and promote solutions that contribute to the development of medicines and healthcare products.

The forum meets periodically to make joint proposals to the administration to improve the quality and sustainability of healthcare. The Biomedical Industries Forum is based on debate, prospective analysis and channelling ideas and projects that are useful to the administration and society as a whole.
 

A collaboration agreement has been established with the Academy to carry out scientific activities and projects through joint training activities with the Catalan Society for Medical Biotechnology.

Plus, the agreement includes a research grant in medical biotechnology, dissemination of the services AseBio offers the foundation’s research project leaders, and hosting various events.
 

Since 2008, AseBio has managed the annual ICEX Internationalisation Plan for the biotechnology sector. The sector plans include coordinated internationalisation activities for a specific sector targeting one or several markets, seeking to benefit participating companies directly and the whole sector indirectly.

The collaborating organisations recognised by the Secretariat of State for Trade are also recognised by ICEX through a collaboration agreement.
 

INE and AseBio have established an agreement to exchange knowledge and experience in order to optimise the compilation of statistics on the use of biotechnology in the business sector.

AseBio and the Japan Bioindustry Association (our Japanese counterpart) have signed a memorandum of understanding that aims to create an agenda with strategic areas of common interest, maximise the benefits for members of both associations, use both organisations’ network of contacts, integrate activities and share ideas and expertise.

Cooperating to draft and disseminate monographs, studies, Technology Watch Bulletins and reports on specific topics of interest to Spanish companies, foundations and associations. Specifically, a quarterly Technology Watch Bulletin featuring a selection of the latest biotechnology patents in the world, in four specific lines of research:

  - Nervous system

  - Immune system

  - Diabetes

  - Macular degeneration

Additionally, the collaboration also covers cooperation to raise awareness of the industrial property protection system and to establish a mechanism to resolve any doubts directly with those in charge of IP and host training sessions.

We have a collaboration agreement with the Madrid Science Park that gives its member companies preferential terms for joining AseBio. Plus, we also work with the Park to exploit data on industrial property for our yearly report.

RAICEX and AseBio work together to promote initiatives that help attract and promote the talent of Spanish scientists abroad.

AseBio is a protector member of the Spanish Society of Biotechnology (Sebiot), the scientific sister society of AseBio that works to promote the development of biotechnology in Spain in all its branches and activities.

AseBio and Sebiot share missions and goals and collaborate on joint projects, particularly those geared towards fostering cooperation among researchers and companies, as well as activities to raise awareness of biotechnology in society.

AseBio is recognised as a Collaborating Organisation of the Secretariat of State for Trade under the Spanish Ministry of Industry, Trade and Tourism as an Association of Exporters.

The activities carried out by associations of exporters effectively contribute to maintaining the presence of Spanish products abroad, enabling their access to new markets. This gives the association access to the grants laid out in current regulations.
 

In 2019, AseBio and the Taiwan European Biotech Association signed a collaboration agreement allowing the two to join forces to promote contacts and joint projects in their respective networks. The Taiwan European Biotech Association brings together international pharmaceuticals working in Europe with roots in Taiwan. 

Taiwan’s special economic and legal conditions make it a gateway to China. Plus, its openness to Europe and widespread fluency in both Mandarin and English make the country a perfect springboard into Asian markets for Spanish biotech companies.
 

AseBio and the Virginia Beach Department of Economic Development in the United States have a memorandum of understanding that aims to help Spanish biotechnology companies with their landing in Virginia Beach.

This city has a bioincubator with advantageous legal and fiscal conditions for biotech companies looking to set up there.